Takeda Pharmaceutical Co Ltd (TAK) stock
TAKNYSEPharmaceutical PreparationsAlso trades as TKPHF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$21.64+0.05 (+0.23%)
Close on Nov 17, 2026Market cap $74.58BP/E –Yield –
Takeda Pharmaceutical EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Takeda Pharmaceutical's EV/EBITDA was 20.3× on Nov 11, 2026, against 10.2× a year earlier. Over the last 5 years it ranged from 8.1× to 20.3×, with a median of 10.0×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 20.3× | +9.5 |
| 2025 | Dec 31, 2025 | 10.8× | −0.9 |
| 2024 | Dec 31, 2024 | 11.7× | +2.8 |
| 2023 | Dec 29, 2023 | 8.8× | −0.7 |
| 2022 | Dec 30, 2022 | 9.6× | +1.5 |
| 2021 | Dec 31, 2021 | 8.1× | −7.1 |
| 2020 | Dec 31, 2020 | 15.2× | −9.1 |
| 2019 | Dec 31, 2019 | 24.2× | +15.6 |
| 2018 | Dec 31, 2018 | 8.6× | −5.9 |
| 2017 | Dec 29, 2017 | 14.5× | – |
See a number that looks wrong?